RITA has agreed with Medtronic, Inc.
to collaborate to increase the access of clinicians
and patients to therapies for cancer pain and for hepatic
arterial infusion ("HAI") in the treatment
of primary and metastatic liver cancer.
For additional information regarding
the SynchroMed® Infusion System for treatment of
cancer pain, click here.
For additional information regarding
the IsoMed® Constant-Flow Infusion System for HAI,
click here.
SynchroMed® and IsoMed® are
registered trademarks of Medtronic, Inc.
